Overview

Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Succinate Metoprolol(Betaloc ZOK®) (95 - 190 mg) on heart rate in the Stable angina patients.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Metoprolol